SDC2 and colonic neoplasm: Indeed, shed syndecan-2 enhanced the tumorigenic characteristics of colon cancer cells in an autocrine manner (Figure 2), potentially affecting both the primary tumor growth (Figure 3) and the metastatic ability of colon cancer cells (Figure 4).